Revenue: The sum of all revenue fields included for a company's operating activities.
Lyra Therapeutics, Inc. (LYRA) had Revenue of $0.01M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$0.01M |
$-6.95M |
|
-- |
|
$0.01M |
|
$7.12M |
|
$-7.12M |
|
$0.17M |
|
$-6.95M |
|
$-6.95M |
|
$-6.96M |
|
$-6.96M |
|
$-6.96M |
|
$-6.96M |
|
$-7.12M |
|
$-7.02M |
|
1.55M |
|
1.55M |
|
$-3.23 |
|
$-3.23 |
|
| Balance Sheet Financials | |
$16.27M |
|
$1.05M |
|
$19.84M |
|
$36.11M |
|
$9.52M |
|
-- |
|
$37.30M |
|
$46.83M |
|
$-10.72M |
|
$-10.72M |
|
$-10.72M |
|
1.77M |
|
| Cash Flow Statement Financials | |
$-28.86M |
|
$-0.10M |
|
$4.27M |
|
$42.57M |
|
$17.89M |
|
$-24.68M |
|
$2.33M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.71 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-101685.80% |
|
-101685.70% |
|
-- |
|
-99271.47% |
|
-99300.02% |
|
$-28.96M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
64.92% |
|
64.92% |
|
-19.27% |
|
64.92% |
|
$-6.04 |
|
$-18.65 |
|
$-18.58 |
|